Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
FAM / First/Trust Aberdeen Global Opportunity Income Fund VOTING RECORD SUMMARY

2018-07-19 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act File No. 811-21636 First Trust/Aberdeen Global Opportunity Income Fund ------------------------------------------------------------- Exact Name of Registrant as Specified in Declaration of Trust 120 East Liberty Drive, Suite 400, Wheaton, Illinois 60187 --------------------------------------------------------------------------
FAM

0
Second Shipment of PopsyBites are Shipped to Tripifoods

2018-07-19 accesswire
PITTSBURGH, PA / ACCESSWIRE / July 19, 2018 / Unique Foods Corporation (OTC PINK: UPZSD) on May 16th 2018 Buffalo New York based food distributor Tripifoods placed their first order of PopsyBites, a smaller Bite Size version of the award winning PopsyCakes "The First & Only Cupcake Dipped in Chocolate on a Pretzel." As a result of their popular demand Unique Foods is proud to announce, Tripifoods has placed a much larger second order.
FAM

1
The Chemist's CEF Report - June 2018: CEFs Recovering

2018-07-05 seekingalpha
Premium/discounts and z-scores recover for the second month in a row, and are highest since January.
FAM DIAX QQQX SPXX BXMX

0
The First of Long Island Corporation Announces Second Quarter Cash Dividend of $.15 Per Share

2018-06-29 globenewswire
GLEN HEAD, N.Y., June 29, 2018 (GLOBE NEWSWIRE) -- The First of Long Island Corporation (Nasdaq:FLIC) announced today the declaration of a second quarter cash dividend in the amount of $.15 per share. This represents a 7.1% increase over the dividend declared in the same quarter last year. The dividend will be paid on July 19, 2018 to shareholders of record on July 10, 2018.
FAM FLBD

31
Reasons To Buy Dollar General And Perhaps Dollar Tree As Well

2018-06-24 seekingalpha
DG has been a strong long term performer, and has performed well since its re-emergence as a public company in 2009.
DLTR FAM TGT FRED DG THO BIG ROST

0
How Macca’s bag brought down dodgy cop

2018-06-21 ntnews.com.au
On Today’s $50 Dollar Food Challenge we are going head to head with Mcdonalds vs Burger King! Big Mac Vs Whopper! Our 2 Contenders will try to finish $50 worth of food LIVE! Who will win? Who will lose? Watch Live and make sure to drop comments!
FAM

14
'GROW'ing To Short U.S. Global

2018-06-12 seekingalpha
Based on my analysis of U.S. Global's (NASDAQ:GROW) recent 10-Q (found here), I calculate U.S. Global's net asset value (NAV) to be approximately one half of its current market cap and enterprise value.
FAM HVBTF GROW

5
Central Banks' Balance Sheets: The First (And Only?) Refuge Of Bears

2018-06-04 seekingalpha
There is no argument that central banks are the single most important single element supporting the markets since 2008.
FAM UNCFY DB UNCRY UNCFF

0
This investor rivals Warren Buffett — and you probably haven’t heard of him - MarketWatch

2018-05-30 marketwatch
The Berkshire Hathaway CEO so admired Lou Simpson that he suggested the Geico CIO could step in for him if needed
FAM

0
FAM / First/Trust Aberdeen Global Opportunity Income Fund QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS (Quarterly Schedule of Portfolio Holdings)

2018-05-27 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-21636
FAM

0
Unique (UPZS) Announces 2017 Revenues of $2.3 Million Up 235% from Previous Year

2018-05-22 globenewswire
PITTSBURGH, Pa., May 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Unique Pizza & Subs Corporation (OTCPK:UPZS) proudly announces their 2017 Year End Financials have been released and with Revenues of $2,303,926 that's a 235% increase in revenue from the previous year.
FAM

156
Bullshit Jobs by David Graeber Review - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FAM AAPL

34
4 Warren Buffett mistakes that can make you a better investor - MarketWatch

2018-05-04 marketwatch
Warren Buffett wants to give back. His way of doing that (apart from helping billion-dollar charities) is to teach others about his investment principles.
BRK.A FAM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to FAM / First/Trust Aberdeen Global Opportunity Income Fund on message board site Silicon Investor.

SI Spammer Hall of Fame Ad Astra - Family and Friends
SI Hall Of Fame Living or dead. DGIV-A-HOLICS...FAMILY CHIT CHAT ONLY!!
Nathanu0027s Famous, Inc. (NATH) Neer Do Well Hall of Infamy
FAMH - FIRAMADA Staffing Services Genealogy and family history stuff
Classic Posts - SI Hall of Fame Internet Property Development Funds... Anyone familiar with